Results 21 to 30 of about 19,422 (137)

Shigella sonnei O-Antigen Inhibits Internalization, Vacuole Escape, and Inflammasome Activation

open access: yesmBio, 2019
Two Shigella species, Shigella flexneri and Shigella sonnei, cause approximately 90% of bacterial dysentery worldwide. While S. flexneri is the dominant species in low-income countries, S.
Jayne L. Watson   +6 more
doaj   +1 more source

Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China.

open access: yesPLoS ONE, 2018
Shigella represents one of the major diarrhea-inducing pathogens threatening public health, but its prevalence and antimicrobial resistance profile in Xinjiang Uygur Autonomous region, China, remains unclear.
Hongbo Liu   +13 more
doaj   +1 more source

Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.

open access: yesPLoS ONE, 2021
IntroductionShigellosis, is a leading cause of moderate-to-severe diarrhoea and related mortality in young children in low and middle income countries (LMICs).
Caroline C Chisenga   +11 more
doaj   +1 more source

Exploring the Sit-and-Wait Potential of the Bacterial Pathogen Shigella flexneri: A Comparative Genomic Study

open access: yesBiology and Life Sciences Forum, 2023
The sit-and-wait hypothesis predicts that bacterial durability in the external environment is positively correlated with the evolution of bacterial virulence.
Bin Gu   +7 more
doaj   +1 more source

Molecular Detection of BlaSHV and Sul2 Genes in Multidrug-Resistant Shigella flexneri from Clinical Specimens in North-East Nigeria

open access: yesUMYU Scientifica Journal
The continued detection and dissemination of multidrug-resistant (MDR) Shigella species pose a significant public health threat worldwide, especially in resource-limited regions such as the Northeast, Nigeria.
Yunusa Saheed   +3 more
doaj   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

open access: yesAngewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber   +4 more
wiley   +1 more source

Finding potential drug targets against Shigella flexneri through druggable proteome exploration.

open access: yesFrontiers in Microbiology, 2016
:Background: Shigella flexneri is a gram negative bacteria that causes the infectious disease ‘shigellosis’. Shigella flexneri (S. flexneri) is responsible for developing diarrhea, fever and stomach cramps in human.
Mohammad Uzzal Hossain   +6 more
doaj   +1 more source

Polycationic Peptide Engineering of Phage Endolysins Expands Host Range and Enhances Antibacterial and Antibiofilm Activities Against Bacillus Species

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT The exponential rise in antimicrobial resistance has highlighted the urgent need for the development of alternative antibacterial strategies, including phage‐derived and engineered protein agents such as endolysins and artilysins. In this study, we report the rational design, expression, and functional characterization of novel artilysins ...
Farhat Ansari, Tarushi, Vandan Nagar
wiley   +1 more source

Vaginal host–microbe signatures linked to placental outcomes in mares

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Ascending placentitis is a leading cause of late‐term pregnancy loss in mares. Although pathogens are presumed to ascend from the caudal reproductive tract, the association between the vaginal microbiome and placentitis has not been systematically examined.
Machteld van Heule   +7 more
wiley   +1 more source

Microbiome—pancreatic cancer crosstalk: From tumor biology to therapeutic intervention

open access: yesiMetaOmics, EarlyView.
The intratumoral microbiome acts as a critical regulator in pancreatic cancer progression and therapeutic resistance. This comprehensive review delineates the origins of pancreatic microbes, elucidates their multifaceted mechanisms in driving immune suppression, metabolic reprogramming, and stromal desmoplasia, and highlights the clinical potential of ...
Yuqin Xie   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy